Last reviewed · How we verify
NCT03916939: OSTEOOL
Osteopathic Treatment to Alcohol Withdrawal Syndrome
NA trial testing osteopathy in Alcohol Withdrawal in 50 participants. Status unknown.
13 December 2023
Quick facts
| Lead sponsor | Centre Hospitalier Intercommunal Creteil |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 26 September 2018 |
| Primary completion | 13 December 2023 |
| Estimated completion | 13 February 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- osteopathy
- simulated osteopathy
Conditions studied
- Alcohol Withdrawal — all drugs for Alcohol Withdrawal →
Sponsor
Centre Hospitalier Intercommunal Creteil
Who can join
18 and older, any sex, with Alcohol Withdrawal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation. The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions. Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03916939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of osteopathy
Trials testing the same drug.
- NCT05664230 — Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pediatrics · unknown
- NCT03382236 — Evaluating the Effectiveness of Osteopathy in the Management of Pain in Elderly People · NA · unknown
Other recruiting trials for Alcohol Withdrawal
Currently open trials in the same condition.
- NCT06771037 — Use of tAN® in Alcohol Withdrawal Management · NA · recruiting
- NCT06618755 — Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool · NA · recruiting
- NCT06878287 — Bright Light Therapy During Residential Alcohol Withdrawal · NA · recruiting
- NCT04793685 — Prazosin for Alcohol Use Disorder With Withdrawal Symptoms · Phase 2 · recruiting
Other Centre Hospitalier Intercommunal Creteil trials
Trials by the same sponsor.
- NCT07493785 — Dexmedetomidine for Invasive Ventilation In the NEOnate · Phase 2, PHASE3 · not yet recruiting
- NCT07513051 — DIaphragmatic Swing According to Cpap Flow Output in NEOnates (DISCONEO) · NA · not yet recruiting
- NCT07455942 — Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer · not yet recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
- NCT06339450 — Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03916939 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Intercommunal Creteil
- Last refreshed: 6 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03916939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing